FindTrial
Sign In

In toto Removal of Bladder Tumor with Laser versus Piecemeal removal to see efficacy and safety of laser removal in patients with bladder tumor

Holmium LASER enbloc Transurethral Resection of Bladder Tumor (HoL-ERBT) Vs Conventional Transurethral Resection of Bladder Tumor (cTURBT) for primary bladder tumors: Randomized controlled trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079699
Enrollment
80
Registered
2025-01-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: Holmium LASER enbloc Transurethral Resection of Bladder Tumor: Device 1: HoLERBT En Bloc resection will be performed at our center using Holmium Quanta System Fiber size 272 micron En

Sponsors

Dr Aquib Javed Mubarak Ali Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients diagnosed with Bladder Mass 2. Size of tumour up to 4 cm 3. No invasion of adjacent organs 4. Up to 4 tumours in number.

Exclusion criteria

Exclusion criteria: 1. Not Fit for Surgery. 2. Patient refused to participate. 3. Tumor larger than 4 cm in size. 4. Tumors more than 4 in number.

Design outcomes

Primary

MeasureTime frame
Comparison of histopathological parameters (Deep Muscle Presence, Cautery Artefact) in HoL-ERBT and cTURBTTimepoint: 14 days, 6 weeks, 6 months—

Secondary

MeasureTime frame
1. To assess efficiency of HoL-ERBT vs cTURBT in terms of complete resection of tumor. 2. Compare peri-operative complications. 3. To compare oncological outcomes between two modalities. Timepoint: 6 weeks, 6 months—

Countries

India

Contacts

Public ContactDr Gautam Ram Choudhary

AIIMS Jodhpur

gautamoshu@gmail.com9414294982

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026